![glp 1 antidiabetic Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. Smell PDF] GLP-1 Based Combination Therapy](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3930385936589782759)
glp 1 antidiabetic Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. Smell PDF] GLP-1 Based Combination Therapy
USD26.08
USD63.08
Pay in 4 interest-free payments of $6.52 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
![glp 1 antidiabetic Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. Smell PDF] GLP-1 Based Combination Therapy](https://figures.semanticscholar.org/73983626886b6439761b6844997806367e881df8/3-Figure1-1.png)
![glp 1 antidiabetic Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. Smell PDF] GLP-1 Based Combination Therapy](https://hsph.harvard.edu/wp-content/uploads/2023/12/iStock-1702335323-scaled-1.jpg)
![glp 1 antidiabetic Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. Smell PDF] GLP-1 Based Combination Therapy](https://figures.semanticscholar.org/d4633364bbf2cc67e74fd3a60dd5180b7e50f90a/8-Table2-1.png)
![glp 1 antidiabetic Use of GLP-1 receptor agonists was associated with a higher risk of smell and taste disturbances among adults with type 2 diabetes, an analysis of electronic health record (EHR) data suggested. Smell PDF] GLP-1 Based Combination Therapy](https://www.frontiersin.org/files/Articles/1163288/xml-images/fimmu-14-1163288-g001.webp)
